Health insights – the problem with society health at large
Access to quality and affordable healthcare is a contentious issue in many parts of the world. The topic dominates political, financial and domestic discussions all over the world because this is a sector facing a myriad of challenges. The fall of healthcare systems has been witnessed in failed states in various parts of the world. From these experiences, it’s apparent that a sick society can’t be productive and neither can it guard its interests. Fixing the healthcare industry calls for a detailed look at the problem with society health in general.
The problem with society health at large
The government is the biggest healthcare provider in any country. It’s subsequently difficult to separate politics from healthcare issues, and this is often the beginning of all things bad in the sector. Funding is, for example, restricted owing to other socio-political demands, making the building of new health and medical research institutions a dream in many communities.
Politics affects the flow of drugs from the pharmaceutical companies to the people who need them. It dictates the number of healthcare providers that a government health institution can have. This is beside setting the tax perimeters which usually impact negatively on the sector.
A roll back to the pre-antibiotic era
There is a notion that disease-causing pathogens are evolving faster than man’s scientific, social and financial ability to contain them. New strains of ailments arise each day. Global pandemics and the complex art and process of drug and vaccine manufacture aren’t making the situation better.
The society isn’t also able to roll out sufficient health experts and retrain them from time to time to help the face and overcome the threat posed by disease pathogen mutation. It follows that diseases are likely to carbon date man before man musters the ability to carbon date them.
The rise of the global population is an issue of concern among the healthcare stakeholders. The fact that there are billions of people in the world with different genetic orientation is a problem enough since it makes medicine, as a science, more complicated. Not even the pharmaceutical companies are able to find ways to produce medical drugs of different kinds to suppress the demand created by the difference in human genes.
A lot of cash is subsequently splashed on family planning programs to help contain the negative effects of population outburst on the social healthcare systems. This denies the health institutions the resources that they need to combat other challenges in the industry.
Waste and mismanagement in the health sector is an open secret. Setting the priorities straight in the health sector has proved to be as difficult as doing the same in any other industry. This is because the health industry is huge and complicated. Streamlining it requires time and resources. It means getting ridding of the existing problems using a systemic framework which isn’t easy to formulate because one framework can’t be applied across the board in all institutions.
Policy and opinion shaping is also a major factor in getting things right, but it isn’t possible to create them squarely owing to divergent views. The medical industry’s overseers are spread thin as well. Consequently, it’s difficult to weed out pranksters in the sector.